Previous 10 | Next 10 |
Image source: The Motley Fool. Akorn (NASDAQ: AKRX) Q3 2019 Earnings Call Oct 31, 2019 , 10:00 a.m. ET Operator Continue reading
Akorn, Inc. (AKRX) Q3 2019 Earnings Conference Call October 31, 2019, 10:00 ET Company Participants Jennifer Bowles - SVP, Corporate Strategy Douglas Boothe - President, CEO & Director Duane Portwood - EVP & CFO Conference Call Participants David Amsellem - Piper Ja...
Akorn ( AKRX +1.7% ) is up in early trade, albeit on light volume, on the heels of preliminary Q3 results . Highlights: More news on: Akorn, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Akorn (NASDAQ: AKRX ): Q3 Non-GAAP EPS of $0.02 beats by $0.06 ; GAAP EPS of $0.38 beats by $0.71 . More news on: Akorn, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
LAKE FOREST, Ill., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its preliminary financial results for the third quarter of 2019. Third Quarter 2019 and Recent Business Highlights Net revenue was $176 million...
The FDA approves Akorn's (NASDAQ: AKRX ) betamethasone dipropionate lotion USP (augmented), 0.05%, a topical corticosteroid for the treatment of inflammatory skin conditions. More news on: Akorn, Inc., Healthcare stocks news, Stocks on the move, Read more ...
LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for betamethasone diprop...
LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it plans to issue a press release before market open on Thursday, October 31, 2019 outlining its third quarter 2019 financial resu...
After losing more than 77% of its total enterprise value in less than four years, Akorn, Inc. ( AKRX ) is a name to be followed carefully. The most significant risk is the company’s financial debt, which does not justify the current low valuation. Besides, Akorn recently announced tha...
Gainers: Helios and Matheson Analytics ( OTCPK:HMNY ) +42% . McDermott International (NYSE: MDR ) +31% . Midatech Pharma plc (NASDAQ: MTP ) +30% . Stage Store (NYSE: SSI ) +26% . San Juan Basin Royalty Trust (NYSE: SJT ) +20% . Interlink Electronics ( OTCPK:LINK ) +20% . California ...
News, Short Squeeze, Breakout and More Instantly...
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg PR Newswire GURNEE, Ill. , Aug. 16, 2022 /PRNewswire/ -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic v...
LAKE FOREST, Ill. , May 20, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company ("Akorn" or the "Company"), today announced that the Company and its U.S. subsidiaries filed for voluntary protection under Chapter 11 ("Chapter 11") of the U.S. Bankrup...
Are These On Your List Of Penny Stocks To Watch This Week? It can be tough at times to trade penny stocks . Some days there are only a few names to choose from. But there are other days where there seems to be plenty of penny stocks to buy . In either case, having your plan in place can defi...